SCHEMBL7994674

SCHEMBL7994674

CCCCCCCCC=CCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 6/20 0.62
PDE4A P27815 5/20 0.62
PDE4B Q07343 4/20 0.62
PDE4C Q08493 4/20 0.62
PDE4D Q08499 4/20 0.62
TNF P01375 3/20 0.62
CYP1A2 P05177 3/20 0.62
PMP22 Q01453 3/20 0.62
LMNA P02545 2/20 0.62
NFKB1 P19838 2/20 0.62
ACHE P22303 2/20 0.62
USP2 O75604 1/20 0.62
TSHR P16473 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
RXFP1 Q9HBX9 1/20 0.62
ADORA2A P29274 3/20 0.62
CHIT1 Q13231 1/20 0.57
CHIA Q9BZP6 1/20 0.57
BLM P54132 3/20 0.57
CYP3A4 P08684 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7994672 1.00 ADORA2B (0.62) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL8431058 0.98 ADORA2B (0.60) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL8431062 0.98 ADORA2B (0.60) ADORA2BPDE4APDE4BPDE4CPDE4D
Pentifylline SCHEMBL147256 0.94 PDE4A (0.70) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL27348729 0.94 PDE4A (0.70) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL23144749 0.94 PDE4A (0.70) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL27334771 0.94 PDE4A (0.70) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL8072025 0.93 ADORA2B (0.62) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL8430990 0.93 ADORA2B (0.62) ADORA2BPDE4APDE4BPDE4CPDE4D
SCHEMBL8076045 0.93 ADORA2B (0.62) ADORA2BPDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6121270-A N-(EPOXYALKYL)XANTHINE DERIVATIVES WHICH MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI CELL THERAPEUTICS, INC. (US) 2000-09-19 US disclosed
US-6100271-A Therapeutic compounds containing xanthinyl CELL THERAPEUTICS, INC. (US) 2000-08-08 US disclosed
US-6043250-A Methods for using therapeutic compounds containing xanthinyl CELL THERAPEUTICS, INC. (US) 2000-03-28 US disclosed
US-5866576-A COMPOUNDS THAT ACT AS DRUGS ON THE CELLULAR AND BIOCHEMICAL LEVEL TO MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI. CELL THERAPEUTICS, INC. (US) 1999-02-02 US disclosed
US-5859017-A PREVENTING OR TREATING ALLERGIES; INHIBITING INTRACELLULAR GENERATION OF PHOSPHATIDIC ACID AND DIACYLGLYCEROL CELL THERAPEUTICS, INC. (US) 1999-01-12 US disclosed
US-5807862-A Therapeutic compounds containing pyrimidinyl moieties CELL THERAPEUTICS, INC. (US) 1998-09-15 US disclosed
US-5521315-A Olefin substituted long chain compounds CELL THERAPEUTICS, INC. (US) 1996-05-28 US disclosed
WO-1995026722-A1 METHOD FOR INHIBITING MAST CELL AND BASOPHIL ACTIVATION CELL THERAPEUTICS, INC. (US) 1995-10-12 WO disclosed